From technological advances to biological understanding: The main steps toward high-precision RT in breast cancer.

[1]  C. Garibaldi,et al.  Recent advances in radiation oncology , 2017, Ecancermedicalscience.

[2]  Consuelo Morigi,et al.  Highlights from the 15th St Gallen International Breast Cancer Conference 15–18 March, 2017, Vienna: tailored treatments for patients with early breast cancer , 2017, Ecancermedicalscience.

[3]  J. Lagendijk,et al.  Quantification of intra-fraction motion in breast radiotherapy using supine magnetic resonance imaging , 2016, Physics in medicine and biology.

[4]  Richard Pötter,et al.  5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial , 2016, The Lancet.

[5]  M. Morrow,et al.  Addressing Overtreatment in DCIS: What Should Physicians Do Now? , 2015, Journal of the National Cancer Institute.

[6]  M. J. van de Vijver,et al.  Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer. , 2015, International journal of radiation oncology, biology, physics.

[7]  J. Yarnold,et al.  Hypofractionated radiotherapy in early breast cancer: Clinical, dosimetric and radio-genomic issues. , 2015, Breast.

[8]  R. Orecchia,et al.  New frontiers in proton therapy: applications in breast cancer , 2015, Current opinion in oncology.

[9]  C. Ward,et al.  Technical innovation in adjuvant radiotherapy: Evolution and evaluation of new treatments for today and tomorrow. , 2015, Breast.

[10]  G. Marta,et al.  Postoperative nodal irradiation in breast cancer patients with 1 to 3 axillary lymph nodes involved: the debate continues… , 2015, Expert review of anticancer therapy.

[11]  Sébastien Clippe,et al.  Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial☆ , 2015, EBioMedicine.

[12]  M. Hou,et al.  Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result. , 2015, Breast.

[13]  E. Connolly,et al.  Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy , 2015, SpringerPlus.

[14]  Laurence Collette,et al.  Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. , 2015, The New England journal of medicine.

[15]  H. Struikmans,et al.  Regional Nodal Irradiation in Early-Stage Breast Cancer. , 2015, The New England journal of medicine.

[16]  Wei Shi,et al.  Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Bellon.  Personalized Radiation Oncology for Breast Cancer: The New Frontier. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  R. Gelber,et al.  Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  A. Luini,et al.  Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  L. Livi,et al.  Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. , 2015, European journal of cancer.

[21]  M. Moran.  Radiation therapy in the locoregional treatment of triple-negative breast cancer. , 2015, The Lancet. Oncology.

[22]  R. Allison,et al.  Radiation oncology: physics advances that minimize morbidity. , 2014, Future oncology.

[23]  Tejinder Kataria,et al.  Image Guidance in Radiation Therapy: Techniques and Applications , 2014, Radiology research and practice.

[24]  Mert R. Sabuncu,et al.  Multi-atlas segmentation of biomedical images: A survey , 2014, Medical Image Anal..

[25]  X. Li,et al.  Adaptive replanning to account for lumpectomy cavity change in sequential boost after whole-breast irradiation. , 2014, International journal of radiation oncology, biology, physics.

[26]  R. Jagsi,et al.  Radiation field design in the ACOSOG Z0011 (Alliance) Trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  D. Wiant,et al.  Surface imaging‐based analysis of intrafraction motion for breast radiotherapy patients , 2014, Journal of applied clinical medical physics.

[28]  T. Sørlie,et al.  Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer , 2014, Acta oncologica.

[29]  P. Graham.  Cardiac dosimetry for adjuvant left‐sided breast radiotherapy: Patterns with 2D‐ versus 3D‐era planning and correlates of coronary dose with maximum depth of myocardial exposure , 2014, Journal of medical imaging and radiation oncology.

[30]  F. Vicini,et al.  Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  EBCTCG (Early Breast Cancer Trialists' Collaborati.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials , 2014, The Lancet.

[32]  G. Pond,et al.  Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  H. Marsiglia,et al.  The use of radiotherapy for early breast cancer in woman at different ages , 2014, Clinical and Translational Oncology.

[34]  T. Kearney,et al.  Basal Subtype, as Approximated by Triple-Negative Phenotype, is Associated with Locoregional Recurrence in a Case–Control Study of Women with 0–3 Positive Lymph Nodes After Mastectomy , 2014, Annals of Surgical Oncology.

[35]  L. Esserman,et al.  Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial , 2014, The Lancet.

[36]  D. Dodwell,et al.  A systematic review of methods to immobilise breast tissue during adjuvant breast irradiation , 2014 .

[37]  A. Luini,et al.  Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. , 2013, The Lancet. Oncology.

[38]  N. Rodríguez,et al.  Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. , 2013, International journal of radiation oncology, biology, physics.

[39]  Do-Hoon Kim,et al.  Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  C. Bourgier,et al.  Genomic classifications and radiotherapy for breast cancer. , 2013, European journal of pharmacology.

[41]  William Small,et al.  Contouring Guidelines for the Axillary Lymph Nodes for the Delivery of Radiation Therapy in Breast Cancer: Evaluation of the RTOG Breast Cancer Atlas. , 2013, International journal of radiation oncology, biology, physics.

[42]  A. Goldhirsch,et al.  Locoregional recurrence in patients with HER2 positive breast cancer. , 2013, Breast.

[43]  A. Goldhirsch,et al.  High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy. , 2013, European journal of cancer.

[44]  T. Major,et al.  Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[45]  K. Mouw,et al.  Hypofractionation in the era of modulated radiotherapy (RT). , 2013, Breast.

[46]  R. Orecchia,et al.  Partial breast irradiation: targeting volume or breast molecular subtypes? , 2013, Breast.

[47]  M. Chun,et al.  Can initial diagnostic PET-CT aid to localize tumor bed in breast cancer radiotherapy: feasibility study using deformable image registration , 2013, Radiation oncology.

[48]  George W. Sledge,et al.  A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast , 2013, Journal of the National Cancer Institute.

[49]  Cyrus Chargari,et al.  Personalized radiation therapy and biomarker-driven treatment strategies: a systematic review , 2013, Cancer and Metastasis Reviews.

[50]  B. Bonanni,et al.  Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype , 2013, British Journal of Cancer.

[51]  A. Ho,et al.  Radiation therapy in the management of breast cancer. , 2013, The Surgical clinics of North America.

[52]  D. Dodwell,et al.  Breast cancer subtypes: response to radiotherapy and potential radiosensitisation. , 2013, The British journal of radiology.

[53]  I. Dumas,et al.  SHARE: a French multicenter phase III trial comparing accelerated partial irradiation versus standard or hypofractionated whole breast irradiation in breast cancer patients at low risk of local recurrence. , 2013, Clinical advances in hematology & oncology : H&O.

[54]  R. Le Scodan,et al.  Prognostic value of molecular subtypes, ki67 expression and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy. , 2012, International journal of radiation oncology, biology, physics.

[55]  E. Moser,et al.  Accelerated partial breast irradiation: the need for well-defined patient selection criteria, improved volume definitions, close follow-up and discussion of salvage treatment. , 2012, Breast.

[56]  B. Haffty,et al.  Basal Subtype, as Approximated by Triple Negative Phenotype, is Associated With Locoregional Recurrence in a Case-control Study of Women With 0-3 Positive Lymph Nodes After Mastectomy , 2012 .

[57]  P. Warde,et al.  Intensity-modulated radiotherapy in the treatment of breast cancer. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

[58]  M. Kerin,et al.  Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype , 2012, Breast Cancer Research and Treatment.

[59]  J. Bergh,et al.  Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design. , 2012, Breast.

[60]  W. Curran,et al.  OT2-06-02: A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) vs Partial Breast Irradiation (PBI) for Women with Stage 0, 1, or 2 Breast Cancer: NSABP B-39/RTOG 0413. , 2011 .

[61]  K. Hunt,et al.  Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  Early Breast Canc Trialists Collab.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011 .

[63]  Barbara L. Smith,et al.  Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  R Peto,et al.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials , 2011, The Lancet.

[65]  D. Wazer,et al.  The Implications of Breast Cancer Molecular Phenotype for Radiation Oncology , 2011, Front. Oncol..

[66]  J. Yarnold,et al.  Planning with intensity-modulated radiotherapy and tomotherapy to modulate dose across breast to reflect recurrence risk (IMPORT High trial). , 2011, International journal of radiation oncology, biology, physics.

[67]  N. Harbeck,et al.  Personalized treatment of early-stage breast cancer: present concepts and future directions. , 2010, Cancer treatment reviews.

[68]  A. Luini,et al.  Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons , 2010, Breast Cancer Research and Treatment.

[69]  P. Canney,et al.  What are the minimal standards of radiotherapy planning and dosimetry for "hypofractionated" radiotherapy in breast cancer? , 2010, Breast.

[70]  I. Olivotto,et al.  Hypofractionation should be the new 'standard' for radiation therapy after breast conserving surgery. , 2010, Breast.

[71]  J. Yarnold,et al.  Hypofractionated radiotherapy for breast cancer. , 2010, The New England journal of medicine.

[72]  A. Luini,et al.  Analysis of local and regional recurrences in breast cancer after conservative surgery. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[73]  T. Nielsen,et al.  Breast cancer subtypes and the risk of local and regional relapse. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  S. Paik,et al.  Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[75]  Anthony Fyles,et al.  Long-term results of hypofractionated radiation therapy for breast cancer. , 2010, The New England journal of medicine.

[76]  Joseph O Deasy,et al.  The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. , 2010, International journal of radiation oncology, biology, physics.

[77]  E. Yorke,et al.  Use of normal tissue complication probability models in the clinic. , 2010, International journal of radiation oncology, biology, physics.

[78]  Corine van Vliet-Vroegindeweij,et al.  Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[79]  J. Yarnold,et al.  Target volume definition for external beam partial breast radiotherapy: clinical, pathological and technical studies informing current approaches. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[80]  R. Pötter,et al.  Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[81]  J. Yarnold,et al.  Localising the tumour bed in breast radiotherapy. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[82]  W. Woodward,et al.  Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. , 2009, International journal of radiation oncology, biology, physics.

[83]  S. O'toole,et al.  Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  Lawrence B Marks,et al.  Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). , 2009, Journal of the American College of Surgeons.

[85]  J. Jassem,et al.  Combining systemic therapies with radiation in breast cancer. , 2009, Cancer treatment reviews.

[86]  C. Coles,et al.  A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[87]  Barbara L. Smith,et al.  Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[88]  F. B. Sørensen,et al.  Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  G. Tienhoven,et al.  Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[90]  Richard Symonds-Tayler,et al.  Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[91]  D. Ash,et al.  A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. , 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

[92]  A. Goldhirsch,et al.  Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[93]  Umberto Veronesi,et al.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.

[94]  J. Vermorken.  Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000, The Lancet.

[95]  M. Harris,et al.  Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[96]  M. Scorsetti,et al.  Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer. , 2016, Breast.

[97]  L. Cuttino.  5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial , 2016 .

[98]  E. van Limbergen,et al.  Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. , 2015, The Lancet. Oncology.

[99]  Mechthild Krause,et al.  ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[100]  T. Whelan,et al.  Regional Nodal Irradiation in Early-Stage Breast Cancer. , 2015, The New England journal of medicine.

[101]  A. Ziegler,et al.  Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivity , 2014, Strahlentherapie und Onkologie.

[102]  B. Haffty.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials: EBCTCG (Early Breast Cancer Trialists' Collaborative Group) () Lancet 383:2127-2135, 2014§ , 2014 .

[103]  Te Vuong,et al.  Past, present, and future of radiotherapy for the benefit of patients , 2013, Nature Reviews Clinical Oncology.

[104]  T. Buchholz,et al.  Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy , 2012 .

[105]  Jan J W Lagendijk,et al.  MRI/linac integration. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[106]  Monica Morrow,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials , 2007 .

[107]  Steve B. Jiang,et al.  The management of respiratory motion in radiation oncology report of AAPM Task Group 76. , 2006, Medical physics.

[108]  G Noël,et al.  [Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials]. , 2001, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[109]  Mike Clarke,et al.  Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000 .